{
    "2020-11-25": [
        [
            {
                "time": "2023-11-25",
                "original_text": "【25日资金路线图】主力资金净流出495亿元 龙虎榜机构抢筹7股",
                "features": {
                    "keywords": [
                        "主力资金",
                        "净流出",
                        "龙虎榜",
                        "机构抢筹"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "综合"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2023-11-26",
                "original_text": "带量集采、医保目录谈判开启，大降价逃不掉，医药股还好吗？",
                "features": {
                    "keywords": [
                        "带量集采",
                        "医保目录",
                        "大降价",
                        "医药股"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2023-11-27",
                "original_text": "【异动股】药明康德(02359-HK)跌3.51%",
                "features": {
                    "keywords": [
                        "药明康德",
                        "异动股",
                        "下跌"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2023-11-28",
                "original_text": "医药保健股再度走弱，爱康医疗跌逾8%",
                "features": {
                    "keywords": [
                        "医药保健股",
                        "走弱",
                        "爱康医疗",
                        "下跌"
                    ],
                    "sentiment_score": -0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2023-11-29",
                "original_text": "【国信医药】全面国际化，迎接“十四五”（2021年度策略）",
                "features": {
                    "keywords": [
                        "国信医药",
                        "国际化",
                        "十四五",
                        "策略"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2023-11-30",
                "original_text": "【医药】阿斯利康新冠疫苗达到主要功效终点，医药进入配置阶段——医药行业周报——中性",
                "features": {
                    "keywords": [
                        "阿斯利康",
                        "新冠疫苗",
                        "主要功效终点",
                        "医药配置",
                        "中性"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}